Cormorant Asset Management, LP - BELLICUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$2,805,000
-53.9%
300,0000.0%0.42%
-41.9%
Q4 2015$6,081,000
+414.5%
300,000
+488.2%
0.73%
+297.8%
Q1 2015$1,182,000
-14.5%
51,000
-15.0%
0.18%
-14.1%
Q4 2014$1,382,00060,0000.21%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,051,441$3,070,0000.79%
X-Square Capital, LLC 109,832$321,0000.25%
KNOTT DAVID M 111,427$325,0000.15%
ARK Investment Management 1,033,491$3,018,0000.12%
Baker Brothers Advisors 2,677,818$7,819,0000.06%
HARVEY CAPITAL MANAGEMENT INC 31,200$91,0000.05%
DAFNA Capital Management LLC 30,000$88,0000.04%
WASATCH ADVISORS LP 953,368$2,784,0000.04%
FRANKLIN STREET ADVISORS INC /NC 51,415$150,0000.02%
FARALLON CAPITAL MANAGEMENT LLC 1,000,000$2,920,0000.02%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders